Le Lézard
Classified in: Covid-19 virus
Subject: Lawsuit

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Gritstone bio, Inc. (GRTS) on Behalf of Investors


Law Offices of Howard G. Smith announces an investigation on behalf of Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS) investors concerning the Company's possible violations of federal securities laws.

On February 12, 2024, Gritstone disclosed that it would be delaying the launch of its COVID-19 vaccine study (the "Phase 2b CORAL Study") from the first quarter of 2024 to Fall 2024 to "allow use of fully GMP-grade raw materials in the vaccine, which is expected to increase the regulatory utility of the trial."

Then, on February 29, 2024, Gritstone announced that it was reducing approximated 40% of its workforce, stating that "[t]he move comes following the recently announced delay of the proposed CORAL Phase 2b study, which resulted in Gritstone not receiving external funding it previously anticipated beginning in 1Q 2024, associated with the initiation of the study."

On this news, Gritstone's stock price fell $0.78, or 27.9%, to close at $2.02 per share on March 1, 2024, thereby injuring investors.

If you purchased Gritstone securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847 or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


These press releases may also interest you

at 10:25
The "Market Trends and Opportunities in Medical Devices: Prosthetics, Dental, Audiology" report has been added to ResearchAndMarkets.com's offering. The 3D printed medical device market will reach $16.5 billion in revenues in 2034 growing from $4.5...

at 10:00
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announces that its self-developed novel Nectin-4-targeting ADC (R&D Code: 9MW2821) has been granted Fast Track Designation (FTD) by the U.S. Food and Drug...

at 10:00
NAIOP, the Commercial Real Estate Development Association, commends the introduction of the "Revitalizing Downtowns and Main Streets Act," which establishes a new 20% tax credit to make possible conversion of many underutilized or vacant commercial...

at 09:45
Telus Corp. has informed some 150 unionized call centre employees based in Ontario that they must relocate to Montreal by October or have their employment terminated with a severance package. The United Steelworkers union (USW) Local 1944,...

at 09:30
French Language Services Commissioner Carl Bouchard today released a report urging the Ontario government to make all of its out-of-home advertising bilingual, after his latest investigation found it systematically failed to meet its obligations...

at 09:05
Flowserve Corporation , a leading provider of flow control products and services for the global infrastructure markets, announced today that it plans to release its second quarter 2024 results after the close of the New York Stock Exchange on...



News published on and distributed by: